| Literature DB >> 18825165 |
Yan-Dong Wang1, Wei-Dong Chen, David D Moore, Wendong Huang.
Abstract
Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18825165 DOI: 10.1038/cr.2008.289
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617